EQUILLIUM, INC. Capital Expenditures
EQUILLIUM, INC. (EQ) reported Capital Expenditures of $74.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $71.00K.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.00K, a 25.00% decline year-over-year.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $44.00K, a 1000.00% increase year-over-year.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $48.00K, a 43.53% decline from fiscal 2024.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $85.00K, a 70.00% increase from fiscal 2023.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $50.00K, a 82.08% decline from fiscal 2022.
- EQUILLIUM, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $279.00K, a 389.47% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 10 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $74.00K 10-Q · filed 2026-08-13 | $118.00K derived: sum of 3 quarters · filed 2026-08-13 | $118.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-13 | $47.00K derived: sum of 2 quarters · filed 2026-05-13 | $47.00K derived: sum of 3 quarters · filed 2026-05-13 | $47.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $44.00K derived: sum of 2 quarters · filed 2026-03-25 | $44.00K derived: sum of 3 quarters · filed 2026-08-13 | $48.00K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $4.00K 10-Q · filed 2025-11-13 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.00K 10-Q · filed 2026-08-13 | $8.00K derived: sum of 3 quarters · filed 2026-08-13 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-13 | $8.00K derived: sum of 2 quarters · filed 2026-05-13 | $8.00K derived: sum of 3 quarters · filed 2026-05-13 | $70.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.00K derived: sum of 2 quarters · filed 2026-03-25 | $66.00K derived: sum of 3 quarters · filed 2026-03-25 | $85.00K 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $62.00K derived: sum of 2 quarters · filed 2025-11-13 | $81.00K 10-Q · filed 2025-11-13 | $116.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $81.00K 10-Q · filed 2025-08-14 | $116.00K derived: sum of 3 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $19.00K 10-Q · filed 2025-05-14 | $54.00K derived: sum of 2 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $50.00K 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-13 | ||||||
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.00K derived: sum of 2 quarters · filed 2024-03-25 | $56.00K derived: sum of 3 quarters · filed 2024-03-25 | $279.00K 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $54.00K derived: sum of 2 quarters · filed 2023-11-08 | $277.00K 10-Q · filed 2023-11-08 | $277.00K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $277.00K 10-Q · filed 2023-08-09 | $277.00K derived: sum of 3 quarters · filed 2023-08-09 | $311.00K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $223.00K 10-Q · filed 2023-05-11 | $223.00K derived: sum of 2 quarters · filed 2023-05-11 | $257.00K derived: sum of 3 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $34.00K derived: sum of 2 quarters · filed 2023-03-23 | $57.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $57.00K 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $23.00K 10-Q · filed 2022-08-15 | ||||||
| 2020-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $187.00K derived: sum of 2 quarters · filed 2022-03-23 | $187.00K derived: sum of 3 quarters · filed 2022-03-23 | $202.00K 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $157.00K derived: sum of 2 quarters · filed 2021-11-10 | $172.00K 10-Q · filed 2021-11-10 | $190.00K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $15.00K 10-Q · filed 2021-08-10 | $33.00K derived: sum of 3 quarters · filed 2021-08-10 | $33.00K derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-13 | $33.00K derived: sum of 2 quarters · filed 2021-05-13 | $33.00K derived: sum of 3 quarters · filed 2021-05-13 | $78.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $18.00K derived: sum of 2 quarters · filed 2021-03-24 | $63.00K derived: sum of 3 quarters · filed 2021-03-24 | $74.00K 10-K · filed 2021-03-24 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $45.00K derived: sum of 2 quarters · filed 2020-11-10 | $56.00K 10-Q · filed 2020-11-10 | $66.00K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $56.00K 10-Q · filed 2020-08-12 | $66.00K derived: sum of 3 quarters · filed 2020-08-12 | $69.00K derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | $11.00K 10-Q · filed 2020-05-13 | $21.00K derived: sum of 2 quarters · filed 2020-05-13 | $24.00K derived: sum of 3 quarters · filed 2020-05-13 | $41.00K derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $13.00K derived: sum of 2 quarters · filed 2020-03-26 | $30.00K derived: sum of 3 quarters · filed 2020-03-26 | $35.00K 10-K · filed 2020-03-26 | $34.86K 10-K · filed 2019-03-27 | ||
| 2018-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $20.00K derived: sum of 2 quarters · filed 2019-11-12 | $25.00K 10-Q · filed 2019-11-12 | $25.38K 10-Q · filed 2018-11-15 | |||
| 2018-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $22.00K 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | $5.00K 10-Q · filed 2019-05-13 | ||||||
| 2017-12-31 | $2.20K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |